BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 3, 2026
Home » Authors » Nuala Moran

Articles by Nuala Moran

FBI: Biotech Industry Not Facing Serious Problem' Of Extremists

June 21, 2004
By Nuala Moran

Strakan, ProSkelia Merging, Building 'Company To Last'

June 16, 2004
By Nuala Moran

Vectura, Evolutec File To Try IPO Luck On London Market

June 16, 2004
By Nuala Moran
LONDON - There are further signs that the UK's initial public offering drought might be nearing an end, as Vectura Ltd. and Evolutec Group plc announced plans to float on London's Alternative Investment Market, looking for £20 million to £25 million (US$32.3 million to US$45.3 million) and £7.5 million, respectively. (BioWorld International)
Read More

Vectura, Evolutec File To Try IPO Luck On London Market

June 16, 2004
By Nuala Moran
LONDON - There are further signs that the UK's initial public offering drought might be nearing an end, as Vectura Ltd. and Evolutec Group plc announced plans to float on London's Alternative Investment Market, looking for £20 million to £25 million (US$32.3 million to US$45.3 million) and £7.5 million, respectively. (BioWorld International)
Read More

Strakan, ProSkelia Merging, Building 'Company To Last'

June 16, 2004
By Nuala Moran

Cancer Researchers Continue Radioimmunotherapy Exploration

June 11, 2004
By Nuala Moran

Cancer Researchers Continue Radioimmunotherapy Exploration

June 11, 2004
By Nuala Moran

After Many Stops And Starts, Gene Therapy Poised To Deliver

June 9, 2004
By Nuala Moran

UK Officials Continue Campaign To Improve Biotech Environment

June 9, 2004
By Nuala Moran

Countries Throughout The World Promoting Biotech Development

June 9, 2004
By Nuala Moran
Previous 1 2 … 449 450 451 452 453 454 455 456 457 … 537 538 Next

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Nerves within a melanoma tumor

    Innervation can slow, as well as speed, tumor growth, study finds

    BioWorld
    Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing